$IDYA IDEAYA Biosciences, Inc. Insider Trading
Get free email notifications about insider trading in IDEAYA Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IDEAYA Biosciences, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in IDEAYA Biosciences, Inc. for free.
CIK Number: 0001676725
IRS Number: 474268251
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: IDYA
Company Address: 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO 94080
Phone number: 650-443-6209
Former name: Ideaya Biosciences, Inc., date of change: 2016-06-09
IDEAYA Biosciences, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Option Exercise | M | 6.92 | 5,000 | 34,600 | 52,500 | |
May 13 2021 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Sell | S | 20.22 | 5,000 | 101,093 | 98,789 | 103.8 K to 98.8 K (-4.82 %) |
May 13 2021 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Buy | M | 6.92 | 5,000 | 34,600 | 103,789 | 98.8 K to 103.8 K (+5.06 %) |
Feb 26 2021 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Option Exercise | A | 19.52 | 80,000 | 1,561,600 | 80,000 | |
Feb 26 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Option Exercise | A | 19.52 | 45,000 | 878,400 | 45,000 | |
Feb 26 2021 | IDYA | IDEAYA Biosciences ... | Throne Jason | SVP, General Counse ... | Option Exercise | A | 19.52 | 52,500 | 1,024,800 | 52,500 | |
Feb 26 2021 | IDYA | IDEAYA Biosciences ... | Hata Yujiro S | President and CEO | Option Exercise | A | 19.52 | 195,000 | 3,806,400 | 195,000 | |
Feb 26 2021 | IDYA | IDEAYA Biosciences ... | Stone Paul A. | SVP, Chief Financia ... | Option Exercise | A | 19.52 | 80,000 | 1,561,600 | 80,000 | |
Feb 17 2021 | IDYA | IDEAYA Biosciences ... | Kelley Susan L. | Director | Option Exercise | A | 18.91 | 22,000 | 416,020 | 22,000 | |
Feb 17 2021 | IDYA | IDEAYA Biosciences ... | Kelley Susan L. | Director | Option Exercise | A | 18.91 | 22,000 | 416,020 | 22,000 | |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Option Exercise | M | 6.92 | 5,000 | 34,600 | 57,500 | |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Sell | S | 20.74 | 5,000 | 103,697 | 98,789 | 103.8 K to 98.8 K (-4.82 %) |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Dillon Michael P. | SVP, Chief Scientif ... | Buy | M | 6.92 | 5,000 | 34,600 | 103,789 | 98.8 K to 103.8 K (+5.06 %) |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Option Exercise | M | 6.98 | 596 | 4,160 | 33,014 | |
Feb 10 2021 | IDYA | IDEAYA Biosciences ... | Lackner Mark | SVP, Head of Biolog ... | Option Exercise | M | 6.98 | 1,104 | 7,706 | 33,610 |